GHTRX Mutual Fund

NAV$18.55

Fund Essentials - as of Dec 31, 2025

Net Assets
$704M
Expense Ratio
0.89%
Dividend Yield (Current)
1.94%
Holdings
296
Inception Date
Apr 30, 2018
Fund Family
Goldman Sachs Asset Management
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Annually

Performance

YTD+12.51%
1 Year+27.65%
3 Year+21.70%
5 Year+12.24%

Asset Allocation

Stocks: 96.83%
Cash: 3.16%
Other: 0.01%

Top Holdings

View All →
TickerNameWeight
FGTXXGoldman Sachs Financial Square Government Fund3.19%
ASL:ASAsml Holding N.V., Ordinary Shares2.56%
AZN:LNAstraZeneca PLC2.20%
NOVN:SMNovartis Ag Reg2.03%
NESN:SMNestlã S.A., Registered Shares1.64%
Top 10 Concentration: 18.70%Report Date: Dec 31, 2025
Download all 296 holdings for GHTRX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Dividend Yield (Current)
1.94%
Frequency
Annually
Latest Distribution
$0.37
-

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This Mutual Fund
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more

GHTRX Mutual Fund Overview

GHTRX Mutual Fund (Goldman Sachs International Tax-Managed Equity Fund Class R6) is managed by Goldman Sachs Asset Management with $704.1M in net assets. GHTRX expense ratio is 0.89%, holding 296 positions across sectors including Unknown, Financials, Information Technology. Inception date: 2018-04-30.

GHTRX performance shows a YTD return of 12.51%. The 1-year return is 27.65% and the 5-year return is 12.24%. GHTRX dividend yield stands at 1.94%, paid annually.

GHTRX top holdings include Goldman Sachs Financial Square Government Fund (3.2%), Asml Holding N.V., Ordinary Shares (2.6%), AstraZeneca PLC (2.2%), Novartis Ag Reg (2.0%), Nestlã S.A., Registered Shares (1.6%). View all GHTRX holdings, sector breakdown, or dividend history.

GHTRX can be compared against other funds using the overlap calculator or side-by-side comparison tool. GHTRX alternatives are available via the screener, along with tax-loss harvesting opportunities.